Cancer research firm Kite Pharma pays $135M for Santa Monica R&D building

The Gilead Sciences subsidiary continues its expansion in the area

Jan.January 19, 2018 04:30 PM
The research and development building at 1800 Stewart St. in Santa Monica (Credit: Google Maps)

Cancer research firm Kite Pharma is paying $135 million for a 160,000-square-foot research and development building in Santa Monica, adding to its already sizeable footprint there.

The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County, according to CoStar. The deal likely includes a leasehold agreement, because the city owns the land beneath the facility.

The seller is Agensys Inc., whose lease expires in 15 years, with an option to extend to 2042, at $972,000 per year. The company redeveloped the property in 2011, but its parent company, Astellas Pharma Inc., announced last year it would shut down Agensys.

The research facility is about a half-mile from Kite Pharma’s existing 180,000-square-foot headquarters, the Colorado Center. The company has smaller facilities around Santa Monica and a 100,000-square-foot facility in nearby El Segundo, according to CoStar.

The property includes a three-story building and a one-story “retail and amenity building,” according to its listing with HFF. Those consist of research and office space, a conference center, fitness center, and café,

Gilead Sciences acquired Kite Pharma in August for $11.9 billion, calling it a leader in the emerging field of cell therapy. The therapy “uses a patient’s own immune cells to fight cancer,” according to a news release at the time.  [Costar] –Dennis Lynch

Related Articles

From left: Howard Schwimmer and Michael S. Frankel, with 1601 W. Mission Boulevard and 2757 E. Del Amo Boulevard (Credit: Google Maps)

Rexford Industrial adds to LA portfolio with $100M in acquisitions

Andrew McDonald and At Mateo in the Arts District

Cushman’s West Coast chief talks expansion, DTLA market, the death of the starving baby broker & more

3339 Exposition Blvd. and Asher Luzzatto

Luzzatto Co. assembling creative office hub in West Adams

Jason Illoulian and the Cemex plant

Faring makes $30M assemblage play on WeHo/LA border

Adam Shekhter and the 1415 5th Street project

WS Communities boosts affordable housing plans in Santa Monica

From left: Nuveen CEO Vijay Advani, Graymark founder/CEO Brian Hecktman

Graymark, Nuveen pay $97M for El Segundo creative office

La Mirada industrial building

Clarion pays $77M for La Mirada industrial project

510 Park Avenue and CEO of Monster Beverage Rodney Sacks

Monster Beverage affiliate guzzles down industrial project in San Fernando